Related Experiment Videos
[Role of radiotherapy in soft tissue sarcoma]
1Clinique d'oncologie et radiothérapie, centre hospitalier universitaire, Tours, France.
Summary
Adjuvant radiation therapy, particularly external beam and brachytherapy, is crucial for reducing local recurrence in soft tissue sarcomas, especially for high-grade tumors with deep locations or inadequate margins.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Context:
- Soft tissue sarcomas often require adjuvant therapy post-surgery to minimize local recurrence.
- Postoperative external beam irradiation is the standard approach, with evidence supporting its efficacy.
Purpose:
- To review the role and optimal strategies of adjuvant radiation therapy in managing soft tissue sarcomas.
- To evaluate the effectiveness of different radiation modalities, including external beam and brachytherapy.
Summary:
- Radiation therapy, especially external beam irradiation, is a common adjuvant treatment for soft tissue sarcomas, significantly reducing local recurrence rates.
- Recommendations for radiation therapy include cases with deep tumor location, inadequate surgical margins, and high-grade (grade 3) tumors, with doses typically ranging from 55 to 65 Gy.
- While preoperative radiation has been associated with higher wound complication rates, brachytherapy has shown value in reducing local recurrence risk, particularly for high-grade tumors. The combination of external radiation (40-45 Gy) and brachytherapy (15-20 Gy) is considered an optimal adjuvant strategy.
Impact:
- Adjuvant radiation therapy improves local control rates in soft tissue sarcoma patients.
- Optimized radiation protocols, including combined external beam and brachytherapy, can enhance treatment outcomes and reduce recurrence.
- Evidence-based recommendations guide the use of radiation in specific patient subgroups, improving personalized treatment strategies.